Cargando…
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
BACKGROUND: Concomitant chemo-radiotherapy is the reference treatment for non-resectable locally-advanced Non-Small Cell Lung Cancer (NSCLC). Increasing radiotherapy total dose in the whole tumour volume has been shown to be deleterious. Functional imaging with positron emission tomography (PET/CT)...
Autores principales: | Thureau, Sébastien, Dubray, Bernard, Modzelewski, Romain, Bohn, Pierre, Hapdey, Sébastien, Vincent, Sabine, Anger, Elodie, Gensanne, David, Pirault, Nicolas, Pierrick, Gouel, Vera, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199734/ https://www.ncbi.nlm.nih.gov/pubmed/30352608 http://dx.doi.org/10.1186/s13014-018-1147-2 |
Ejemplares similares
-
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers
por: Gouel, Pierrick, et al.
Publicado: (2023) -
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021) -
Synthetic MRI for Radiotherapy Planning for Brain and Prostate Cancers: Phantom Validation and Patient Evaluation
por: Gouel, Pierrick, et al.
Publicado: (2022) -
Prognostic value of post-induction chemotherapy (18)F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation
por: Ganem, Julien, et al.
Publicado: (2019) -
Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy
por: Hinault, Pauline, et al.
Publicado: (2022)